Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01097902 · ClinicalTrials.gov registry record · Phase 1
Study of Experimental Models of Pain and Inflammation.
A Phase 1 study, sponsored by Martin Angst.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01097902 is a Phase 1 study that has completed, run by Martin Angst. The registered enrollment target is 15 participants.
The verdict
NCT01097902, a Phase 1 study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pain. We also hope to determine the measurable effects of a known non-steroidal anti-inflammatory drug (NSAID) on biomarkers of pain and inflammation.
Interventions
- DRUG Ibuprofen
- DRUG Placebo tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01097902
The ClinicalTrials.gov registry entry for NCT01097902 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT01097902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01097902 about?
NCT01097902 is a clinical study titled "Study of Experimental Models of Pain and Inflammation.". The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pa...
What is the current status of trial NCT01097902?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01097902?
The interventions under investigation include: Ibuprofen (DRUG), Placebo tablet (DRUG).
Who is sponsoring clinical trial NCT01097902?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.